Zenith Capital Corp
ZENIp.V
$0.08
Closing
1D
YTD
ZENIp
BBG004NFG2B8
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$565099
Analysts' Rating
-
Price Target (Mean)
0.00
Total Analysts
0
P/E
Operating Margin
0.00%
Beta
Revenue Growth
0.00%
52 week high
$
52 week low
$
Div. Yield
%
EPS Growth
0.00
Company Profile
Zenith Capital Corp. is a Canada-based biotechnology investment company. The Company’s wholly owned subsidiary, Zenith Epigenetics Ltd. (Zenith Epigenetics), is a clinical-stage biotechnology company focused on the discovery and development of therapeutics for the treatment of cancer and other disorders with significant unmet medical needs. Zenith Epigenetics is developing various combinations of bromodomain and extra-terminal (BET) inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for various oncologic indications such as metastatic castration resistant prostate cancer, NUT carcinoma, ovarian cancer and RAS activated tumors.
